Market Place
Sourcing Support
Laurus Labs Reports Consolidated Q3 Net Profit Of Rs. 251.66 Cr
24 Jan 2026 //
INDPHARMAPOST
Laurus Labs Posts Q2 FY26 Consolidated PAT Higher At Rs. 195 Cr
24 Oct 2025 //
INDPHARMAPOST
Laurus Labs Granted 531.77 Acres by Andhra Pradesh Govt.
28 Jul 2025 //
INDPHARMAPOST
Laurus Labs to Invest €5 Million in JV Krka Pharma
27 Jul 2025 //
INDPHARMAPOST
Laurus Labs Consolidated Q1 Fy2026 Pat at Rs. 163.02 Cr
26 Jul 2025 //
INDPHARMAPOST
Laurus Labs Q4 FY25 PAT up 208% to Rs. 234 Cr
24 Apr 2025 //
INDPHARMAPOST
Indian pharma stocks decline after Trump again threatens tariffs
09 Apr 2025 //
REUTERS
Laurus Labs posts Q3 FY25 consolidated PAT higher at Rs. 92.30 Cr
28 Jan 2025 //
INDPHARMAPOST
Laurus Labs invests in Laurus Bio
09 Dec 2024 //
INDPHARMAPOST
Laurus Labs posts Financial Results Q2 FY 2025
24 Oct 2024 //
PRESS RELEASE
Laurus Labs inaugurates new R&D facility at IKP Knowledge Park
19 Sep 2024 //
PRESS RELEASE
Laurus Labs opens new R&D facility in IKP Knowledge Park, Hyderabad
16 Sep 2024 //
ECONOMICTIMES
Laurus Labs Q1 FY25: ?1,195 Cr Revenue, ?171 Cr EBITDA
25 Jul 2024 //
PRESS RELEASE
Laurus Labs CEO confident of strong growth in CDMO business this year
25 May 2024 //
PRESS RELEASE
How Satyanarayana Chava converted Laurus Labs
17 May 2024 //
PRESS RELEASE
Granules India posts Q4 revenue fall on weak paracetamol sales, price erosion
14 May 2024 //
REUTERS
Laurus Labs: CDMO business to accelerate from FY26
29 Apr 2024 //
MONEYCONTROL
Laurus Labs: CDMO services key to improved prospects, say analysts
26 Apr 2024 //
PRESS RELEASE
Laurus Labs posts Q4 FY24 consolidated PAT at Rs. 75.61 Cr
25 Apr 2024 //
INDINPHARMAPOST
Laurus Labs forms JV company
16 Apr 2024 //
INDINPHARMAPOST
Laurus Labs inks JV agreement with KRKA, Slovenia
26 Jan 2024 //
INDIAN PHARMA POST
Laurus Labs posts Q3 FY24 consolidated PAT at Rs. 23.14 Cr
25 Jan 2024 //
INDIAN PHARMA POST
Laurus Labs acquires 87.59% stake in Laurus Bio Private
25 Nov 2023 //
INDIAN PHARMA POST
Laurus Labs Q2 FY24 consolidated PAT up QOQ at Rs. 36.95 Cr
21 Oct 2023 //
INDIAN PHARMA POST
Laurus Labs slumps to 52-week low as Kotak Institutional Equities downgrades
02 Dec 2022 //
MONEYCONTROL
Laurus Labs takes stake in Ethan Energy India
25 Nov 2022 //
INDIANPHARMAPOST
Laurus Labs planning Rs. 2,000 Cr Capex
27 Oct 2022 //
INDIANPHARMAPOST
Laurus Labs will try to make ‘rare’ drugs affordable in India: CEO
03 May 2022 //
ECONOMIC TIMES
Laurus Labs will try to make ‘rare’ drugs affordable in India: CEO
02 May 2022 //
ET HEALTH
Laurus Labs up 8% in two days on purchase orders from global pharma company
11 Feb 2022 //
BUSINESS-STANDARD
Laurus Labs inks pact with MPP to produce molnupiravir
21 Jan 2022 //
ECONOMIC TIMES
Laurus Labs acquires stake in IIT-Bombay incubated CAR-T cell therapy company
19 Nov 2021 //
ECONOMICTIMES
Unitaid, Clinton Health Access Initiative, and Laurus Labs announce agreement
14 Sep 2021 //
PRESS RELEASE
Laurus Labs, Unitaid and CHAI ink agreement for development of HIV medication
14 Sep 2021 //
PHARMABIZ
Laurus Labs hits record high; rallies 17% in 7 days post Q1 results
09 Aug 2021 //
BUSINESS-STANDARD
Laurus Labs gets licence from DRDO to manufacture & market Covid drug 2DG
02 Jul 2021 //
THEHINDU
BSE Healthcare index hits record high; Laurus Labs, Dr Reddy`s at new highs
17 Sep 2020 //
BUSINESS STANDARD
Laurus Labs has gained 3X since we recommended it a year ago. What you do now?
04 Aug 2020 //
MONEYCONTROL
Infosys, HCL Tech, L&T Infotech, Granules, Laurus Labs hit record highs
14 Jul 2020 //
BUSINESSSTANDARD
Laurus Labs falls over 4% on report of block deals worth Rs 673 crore
29 Jun 2020 //
MONEYCONTROL
Laurus Labs under pressure, plunges 10% after multiple block deals
07 May 2020 //
BUSINESS-STANDARD
Rising Pharma & Laurus Labs Partner to Support the University of Minnesota
27 Mar 2020 //
BUSINESSWIRE
Patent for Pharmacyclic`s cancer drug revoked on challenge by Laurus Labs
23 Mar 2020 //
BUSINESS-STANDARD
Laurus Labs gets 3 observations from USFDA for Visakhapatnam facility
22 Nov 2019 //
MONEY CONTROL
Aspen Strikes Deal With India’s Laurus to Cut Cost of HIV Drugs
20 Sep 2019 //
BLOOMBERG
Buy Laurus Labs; target of Rs 470: Motilal Oswal
06 May 2019 //
MONEYCONTROL
Buy Laurus Labs; target of Rs 470: Motilal Oswal
11 Apr 2019 //
MONEYCONTROL
Laurus Labs gets USFDA nod for HIV drug
09 Feb 2019 //
ECONOMIC TIMES
USP’s collaboration builds skill for pharma industry: Dr. Jayesh Ranjan
06 Sep 2018 //
PHARMABIZ
Is It Time For The FDA To Consider A Differentiated Approval System?
04 Dec 2017 //
HEALTHAFFAIRS
Laurus Labs net jumps by 52% in Q1
14 Aug 2017 //
PARMABIZ
India`s Laurus Labs jumps over 16 percent on market debut
19 Dec 2016 //
REUTERS
Telangana regulator inspects 12 units of major pharma firms for quality issues
19 Feb 2016 //
FINANCIAL EXPRESS
Gland Chemicals Receives Written Confirmation of Export of 3 APIs to EU
20 Jan 2016 //
TWOFOUR INSIGHT
Laurus Labs: A Hot Startup In The Pharma Sector
14 Sep 2015 //
FORBES
Laurus Labs Launches New US Affiliate
29 Jan 2015 //
DCAT CONNECT
LAURUS SYNTHESIS INC. LAUNCHED AS U.S. AFFILIATE OF LAURUS LABS PVT, INDIA
28 Jan 2015 //
LAURUS
API Manufacturer Laurus Labs Believes in Excelling in its Chosen Segments, Not in Following Trends
23 Nov 2014 //
BUSINESS TODAY
